- Vaccine Ontology ID: VO_0004734
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- F fusion protein
gene engineering:
- Type: Recombinant vector construction
- Description: Canarypox virus-based vaccine vectors carrying the gene for NiV glycoprotein (ALVAC-G) or the fusion protein (ALVAC-F) (Weingartl et al., 2006).
- Detailed Gene Information: Click Here.
- G glycoprotein
gene engineering:
- Type: Recombinant protein preparation
- Description: Canarypox virus-based vaccine vectors carrying the gene for NiV glycoprotein (ALVAC-G) or the fusion protein (ALVAC-F) (Weingartl et al., 2006).
- Detailed Gene Information: Click Here.
- Vector: ALVAC vaccine vector
- Preparation: Canarypox virus-based vaccine vectors carrying the fusion protein (ALVAC-F) (Weingartl et al., 2006).
- Immunization Route: Intramuscular injection (i.m.)
|
- Vaccine Ontology ID: VO_0004733
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- F fusion protein
gene engineering:
- Type: Recombinant vector construction
- Description: Canarypox virus-based vaccine vectors carrying the gene for NiV glycoprotein (ALVAC-G) or the fusion protein (ALVAC-F) (Weingartl et al., 2006).
- Detailed Gene Information: Click Here.
- G glycoprotein
gene engineering:
- Type: Recombinant protein preparation
- Description: Canarypox virus-based vaccine vectors carrying the gene for NiV glycoprotein (ALVAC-G) or the fusion protein (ALVAC-F) (Weingartl et al., 2006).
- Detailed Gene Information: Click Here.
- Vector: ALVAC vaccine vector
- Preparation: Canarypox virus-based vaccine vectors carrying the gene for NiV glycoprotein (ALVAC-G) (Weingartl et al., 2006).
- Immunization Route: Intramuscular injection (i.m.)
|
- Vaccine Ontology ID: VO_0004714
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- G glycoprotein
gene engineering:
- Type: Recombinant vector construction
- Description: A recombinant measles virus (rMV) vaccine expressing NiV envelope glycoproteins (rMV-HL-G and rMV-Ed-G) (Yoneda et al., 2013).
- Detailed Gene Information: Click Here.
- Vector: measles virus vaccine vector
- Preparation: Recombinant measles virus (rMV) vaccine expressing NiV envelope glycoproteins (rMV-HL-G and rMV-Ed-G) (Yoneda et al., 2013).
- Immunization Route: Intramuscular injection (i.m.)
|
Weingartl et al., 2006: Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Czub M. Recombinant nipah virus vaccines protect pigs against challenge. Journal of virology. 2006; 80(16); 7929-7938. [PubMed: 16873250].
|
Weingartl et al., 2006: Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Czub M. Recombinant nipah virus vaccines protect pigs against challenge. Journal of virology. 2006; 80(16); 7929-7938. [PubMed: 16873250].
|
Yoneda et al., 2013: Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PloS one. 2013; 8(3); e58414. [PubMed: 23516477].
|
